Redmile Group, LLC Regenxbio Inc. Put Options Transaction History
Redmile Group, LLC
- $822 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RGNX
# of Institutions
181Shares Held
45.1MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$69.7 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$35.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$27.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$14.9 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY1.78MShares$14.5 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $350M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...